610 related articles for article (PubMed ID: 29229282)
21. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
22. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M
Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
[TBL] [Abstract][Full Text] [Related]
23. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
24. Current management of complete and partial molar pregnancy.
Goldstein DP; Berkowitz RS
J Reprod Med; 1994 Mar; 39(3):139-46. PubMed ID: 8035368
[TBL] [Abstract][Full Text] [Related]
25. Reproductive outcomes after hydatiform mole and gestational trophoblastic neoplasia.
Gadducci A; Lanfredini N; Cosio S
Gynecol Endocrinol; 2015; 31(9):673-8. PubMed ID: 26288335
[TBL] [Abstract][Full Text] [Related]
26. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
Wolfberg AJ; Feltmate C; Goldstein DP; Berkowitz RS; Lieberman E
Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
[TBL] [Abstract][Full Text] [Related]
27. [Epidemiologic and clinicopathologic studies of partial hydatidiform mole].
Kodama A; Kanazawa K; Honma S; Aoki Y; Tanaka K; Takahashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1219-25. PubMed ID: 1919183
[TBL] [Abstract][Full Text] [Related]
28. Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole.
Bagshawe KD; Lawler SD; Paradinas FJ; Dent J; Brown P; Boxer GM
Lancet; 1990 May; 335(8697):1074-6. PubMed ID: 1970378
[TBL] [Abstract][Full Text] [Related]
29. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
[TBL] [Abstract][Full Text] [Related]
30. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
[TBL] [Abstract][Full Text] [Related]
31. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study.
Yamamoto E; Trinh TD; Sekiya Y; Tamakoshi K; Nguyen XP; Nishino K; Niimi K; Kotani T; Kajiyama H; Shibata K; Le QT; Kikkawa F
Nagoya J Med Sci; 2020 May; 82(2):183-191. PubMed ID: 32581399
[TBL] [Abstract][Full Text] [Related]
32. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study.
Agarwal R; Teoh S; Short D; Harvey R; Savage PM; Seckl MJ
Lancet; 2012 Jan; 379(9811):130-5. PubMed ID: 22130490
[TBL] [Abstract][Full Text] [Related]
34. Current clinical features of complete and partial hydatidiform mole in Sweden.
Joneborg U; Marions L
J Reprod Med; 2014; 59(1-2):51-5. PubMed ID: 24597287
[TBL] [Abstract][Full Text] [Related]
35. Video Hysteroscopy in the Diagnosis of Molar Pregnancy in two Challenging Situations: Complete Mole with Normal hCG and Partial Mole with Early Gestational Age.
Braga A; Padrón L; Balen JL; Elias KM; Horowitz NS; Berkowitz RS
J Minim Invasive Gynecol; 2021 Aug; 28(8):1448-1449. PubMed ID: 33556583
[TBL] [Abstract][Full Text] [Related]
36. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia.
Lertkhachonsuk R; Tantbirojn P; Paiwattananupant K
J Reprod Med; 2012; 57(7-8):333-40. PubMed ID: 22838251
[TBL] [Abstract][Full Text] [Related]
37. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
[TBL] [Abstract][Full Text] [Related]
38. Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?
Braga A; Torres B; Burlá M; Maestá I; Sun SY; Lin L; Madi JM; Uberti E; Viggiano M; Elias KM; Berkowitz RS
Gynecol Oncol; 2016 Dec; 143(3):558-564. PubMed ID: 27640962
[TBL] [Abstract][Full Text] [Related]
39. Current issues in the histopathology of gestational trophoblastic tumors.
Sebire NJ; Lindsay I
Fetal Pediatr Pathol; 2010; 29(1):30-44. PubMed ID: 20055562
[TBL] [Abstract][Full Text] [Related]
40. Inhibin as a marker for hydatidiform mole: a comparative study with the determinations of intact human chorionic gonadotrophin and its free beta-subunit.
Badonnel Y; Barbé F; Legagneur H; Poncelet E; Schweitzer M
Clin Endocrinol (Oxf); 1994 Aug; 41(2):155-62. PubMed ID: 7523000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
